lopinavir has been researched along with Lymphopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JH; Choi, EY; Chung, JH; Hong, KS; Jang, JG; Jin, HJ; Lee, KH; Lee, W; Shin, KC | 1 |
| Cemillán-Fernández, CA; Domingo-García, J; Fouz-Ruiz, D; Gómez-Enjuto, S; Hernando-Requejo, V; Lapeña-Motilva, J; Ogando-Durán, G; Rodríguez-García, E | 1 |
| Gao, C; Jin, CC; Tong, YX; Xiao, AT; Zhang, S; Zhu, L | 1 |
3 other study(ies) available for lopinavir and Lymphopenia
| Article | Year |
|---|---|
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
Topics: Adult; Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Drug Combinations; Female; Humans; Hydroxychloroquine; Intensive Care Units; Lopinavir; Lymphopenia; Male; Middle Aged; Pandemics; Pneumonia, Viral; Republic of Korea; Retrospective Studies; Ritonavir; SARS-CoV-2 | 2020 |
Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
Topics: Aged; Anemia; Anticoagulants; Anticonvulsants; Antiviral Agents; Betacoronavirus; Calcium Channel Blockers; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Enzyme Inhibitors; Humans; Hydroxychloroquine; Lopinavir; Lymphopenia; Male; Pandemics; Pneumonia, Viral; Posterior Leukoencephalopathy Syndrome; Ritonavir; SARS-CoV-2; Status Epilepticus; Verapamil | 2020 |
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; China; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Diabetes Mellitus; Drug Combinations; Female; Hospitalization; Humans; Hydroxychloroquine; Hypertension; Interferons; Lopinavir; Lymphopenia; Male; Middle Aged; Receptors, Interleukin-2; Retrospective Studies; Risk Factors; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tumor Necrosis Factor-alpha; Virus Shedding | 2020 |